THE CURATIVE TREATMENT BY RADIOTHERAPY ALONE OF STAGE-I NON-SMALL-CELL CARCINOMA OF THE LUNG

被引:105
|
作者
GAUDEN, S
RAMSAY, J
TRIPCONY, L
机构
[1] Queensland Radium Institute, Royal Brisbane Hospital, Herston, QLD
关键词
LUNG CANCER; NON-SMALL CELL CANCER; RADIOTHERAPY;
D O I
10.1378/chest.108.5.1278
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
This review was initiated to assess the outcome of treatment with radical radiotherapy with curative intent for patients diagnosed as having stage I non-small cell lung cancer, The study involved a retrospective review of 347 patients with T1 and T2N0M0 tumors treated at the Queensland Radium Institute during the period 1988 to 1992. The main reasons for not proceeding to surgery included poor performance status, old age, or refusal to submit to surgery, The median age for the group was 70 years, with the range being 34 to 90 years, Patients in this group were all treated by a standard technique involving external-beam radiotherapy to 50 Gy, minimum tumor dose, in 20 fractions over 4 weeks, The overall survival rate was 27% at 5 years with a median survival of 27.9 months, The 5-year recurrence-free survival was 23% with the median being 19.5 months, There was a strong correlation of survival to tumor size with g-year survival rates being 32% and 21% for T1 and T2 tumors, respectively, Multivariate analysis found only T stage to be associated with overall survival (p<0.01). In addition, the analysis showed that age younger than 70 years was a prognostic factor that approached statistical significance at the p<0.05 level of significance, We conclude from this large series of patients with stage I non-small cell lung cancer that radical radiotherapy with curative intent may be a viable alternative to surgery in those patients who either refuse surgery or are judged to be unfit for operation.
引用
收藏
页码:1278 / 1282
页数:5
相关论文
共 50 条
  • [21] Involved-field radiotherapy alone for early-stage non-small-cell lung cancer
    Cheung, PCF
    Mackillop, WJ
    Dixon, P
    Brundage, MD
    Youssef, YM
    Zhou, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (03): : 703 - 710
  • [22] NUCLEOLAR ORGANIZER REGIONS AS A PROGNOSTIC INDICATOR FOR STAGE-I NON-SMALL-CELL LUNG-CANCER
    KANEKO, S
    ISHIDA, T
    SUGIO, K
    YOKOYAMA, H
    SUGIMACHI, K
    CANCER RESEARCH, 1991, 51 (15) : 4008 - 4011
  • [23] Treatment of stage I non-small cell lung carcinoma
    Smythe, WR
    CHEST, 2003, 123 (01) : 181S - 187S
  • [24] Novel treatment options in stage I non-small-cell lung cancer
    Tarasevych, Svitlana
    Lauwers, Patrick
    Vandaele, Frederik
    van Meerbeeck, Jan P.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (09) : 1007 - 1020
  • [25] MODALITY OF FAILURE FOLLOWING RESECTION OF STAGE-I AND STAGE-II NON-SMALL-CELL LUNG-CANCER
    RAMACCIATO, G
    PAOLINI, A
    VOLPINO, P
    AURELLO, P
    BALESH, AM
    DANDREA, N
    DELGRANDE, E
    PASSARO, U
    TOSATO, F
    FEGIZ, G
    INTERNATIONAL SURGERY, 1995, 80 (02) : 156 - 161
  • [26] IS CONCOMITANT CISPLATIN AND RADIOTHERAPY MORE EFFICACIOUS TREATMENT THAN RADIOTHERAPY ALONE IN STAGE-III NON-SMALL-CELL LUNG-CANCER
    KOMAKI, R
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 24 (01): : 185 - 186
  • [27] Radiotherapy for Stage III Non-Small-Cell Lung Carcinoma in the Elderly (Age ≥ 70 years)
    Aridgides, Paul D.
    Janik, Adam
    Bogart, Jeffrey A.
    Duffy, Steven
    Rosenbaum, Paula
    Gajra, Ajeet
    CLINICAL LUNG CANCER, 2013, 14 (06) : 674 - 679
  • [28] Impact of the stereotactic irradiation schedule for non-small-cell lung carcinoma stage I
    Duverge, L.
    Bondiau, P.
    Bellec, J.
    Corre, R.
    Ricordel, C.
    De Latour, B.
    Doyen, J.
    De Crevoisier, R.
    Chajon, E.
    Castelli, J.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S757 - S757
  • [29] QUALITY OF LIFE AFTER STEREOTACTIC RADIOTHERAPY FOR STAGE I NON-SMALL-CELL LUNG CANCER
    van Zyp, Noelle C. van der Voort
    Prevost, Jean-Briac
    van der Holt, Bronno
    Braat, Cora
    van Klaveren, Robertus J.
    Pattynama, Peter M.
    Levendag, Peter C.
    Nuyttens, Joost J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (01): : 31 - 37
  • [30] Crizotinib in the treatment of non-small-cell lung carcinoma
    Pluzanski, Adam
    Piorek, Aleksandra
    Krzakowski, Maciej
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2012, 16 (06): : 480 - 484